News Detail

Virax Biolabs to consolidate shares 1-for-25 on June 26

PUBT · 06/24 13:02

Listen to the news

Virax Biolabs to consolidate shares 1-for-25 on June 26

Virax Biolabs set a 1-for-25 share consolidation effective June 26, 2026.
Shares will trade post-consolidation on Nasdaq under VRAX at the open, with CUSIP G9495L133.
Move targets Nasdaq’s $1 minimum bid rule to maintain its Nasdaq Capital Market listing.
Each 25 ordinary shares at US$ 0.001 par value converts into 1 share at US$ 0.025; fractions round up.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606240900PR_NEWS_USPR_____DA90168) on June 24, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.